EDAP TMS SA (EDAP)

$EDAP: Now its called $FOCL.......... at $4.05

EDAP Announces Corporate Name Change to FocalTherics to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
By EDAP TMS S.A. | May 29, 2026, 7:30 AM

Share
, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy

Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June 1, 2026
Company Intends to Report and Classify its Legacy Non-Core ESWL and Distribution Operating Segments as Discontinued Operations Beginning with Second Quarter 2026 Financial Results
Investor Day to be Held on June 1, 2026 to Highlight Company Vision and Long-Term Strategy under New FocalTherics Corporate Identity

AUSTIN, Texas, May 29, 2026 - EDAP TMS S.A. (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will operate under the new corporate name “FocalTherics” to reflect its exclusive and strategic focus on high-growth robotic focal therapy. The Company also announced its intention to report and classify its Extracorporeal Shock Wave Lithotripsy (“ESWL”) and Distribution operating segments as discontinued operations in the Company’s financial statements beginning with second quarter 2026 financial results. In conjunction with this defined focus, the Company is changing its ticker symbol on Nasdaq from “EDAP” to “FOCL”, effective at market open on June 1, 2026.

“FocalTherics is derived from the words ‘Focal Therapy’ and ‘Therapeutics’.” said Ryan Rhodes, Chief Executive Officer. “This new name and identity reflects and reinforces the Company’s emerging leadership in defining, building and driving the growing category of robotic focal therapy. Additionally, our new corporate identity aligns directly with our flagship market leading product brand, Focal One®.”

Rhodes added, “Together, the new corporate name and ticker symbol will create a stronger connection between our company identity, our strategic product brand and the significant opportunity ahead. These combined updates are designed to strengthen how investors, analysts, and stakeholders understand our vision, recognize the momentum of our HIFU business, and appreciate our growing leadership position in Robotic Focal Therapy.”

The ticker symbol change will apply to the Company’s American Depositary Shares, each representing one Ordinary Share (Ordinary Shares, nominal value €0.13 per share). The Company’s legal name will remain EDAP TMS S.A., and the Company intends to submit a corresponding change of legal name for shareholder approval at a future general meeting of the Company’s shareholders. No action is required by shareholders with respect to the name change or ticker symbol change announced today, and these changes will not affect the existing rights of shareholders. Following the ticker symbol change, the American Depositary Shares will continue to be listed on Nasdaq and the CUSIP number will remain unchanged.

The Company will discuss its new corporate identity, growth strategy, and business outlook at the Investor Day scheduled on June 1, 2026 at 8:00 am ET and invites participants to join the event via the Events and Presentations section of the Investor Relations website. A replay of the webcast and associated slide presentation will be available on the Company’s website.

About FocalTherics

A recognized global leader in Robotic Focal Therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life. FocalTherics is committed to expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and global market development initiatives. For more information about FocalTherics, visit FocalTherics.com.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of applicable federal securities laws, including Section 27A of the U.S. Securities Act of 1933 (the “Securities Act”) or Section 21E of the U.S. Securities Exchange Act of 1934, which may be identified by words such as “believe,” “can,” “contemplate,” “could,” “plan,” “intend,” “is designed to,” “may,” “might,” “potential,” “objective,” “target,” “project,” “predict,” “forecast,” “ambition,” “guideline,” “should,” “will,” “estimate,” “expect” and “anticipate,” or the negative of these and similar expressions, which reflect our views about future events and financial performance. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical status and market acceptance of our High Intensity Focused Ultrasound (“HIFU”) devices, risks associated with the intended discontinuation of the Company's ESWL and Distribution operating segments, including that the discontinuation may take longer or cost more than expected, may result in disputes with customers, distributors, employees or other counterparties, and may not produce the strategic benefits anticipated as well as risks associated with the current worldwide inflationary environment, the uncertain worldwide economic, political and financial environment, geopolitical instability, climate change and pandemics, or other public health crises, and their related impact on our business operations, including their impacts across our businesses or demand for our devices and services.

Other factors that may cause such a difference may also include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission and in particular, in the sections "Cautionary Statement on Forward-Looking Information" and "Risk Factors" in the Company's Annual Report on Form 10-K.

Forward-looking statements speak only as of the date they are made. Other than required by law, we do not undertake any obligation to update them in light of new information or future developments. These forward-looking statements are based upon information, assumptions and estimates available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete.

Investor Contact
Louisa Smith
Gilmartin Group
investor.relations@focalone.com


GO $FOCL

EDAP...................................https://stockcharts.com/sc3/ui/?s=EDAP&p=W&b=5&g=0&id=p86431144783

EDAP..................https://stockcharts.com/sc3/ui/?s=EDAP&p=W&b=5&g=0&id=p86431144783

EDAP............................................https://stockcharts.com/h-sc/ui?s=EDAP&p=W&b=5&g=0&id=p86431144783

EDAP bio mini beast

EDAP BIO BEAST READY TO BEAST

edap.................................................https://stockcharts.com/h-sc/ui?s=edap&p=W&b=5&g=0&id=p86431144783

EDAP...$3.62.. https://schrts.co/mPBpzEiE ...🥳Bottom Reversal setting up here...

Anyone interested now?? Good report pop to $20

AH volume Friday, ready to POP?

OT........Just read the post from serafino



How dare YOU post about COOP on the COOP board...the nerve!!!!! SMH

Can't make this shxt up.................

OT .... I answered on the COOP because I thought your post on the Fannie Board was a mistake. Now EDAP? LOL. Are you banned?

I think this one year extension makes only sense after the end of a 3 year period, so it could only be March 2018 to March 2019 or for March 2021 to March 2022. But we will see it, I asked someone from KCCLLC if she knows the answer (and is allowed to answer), but she is out of the office.

Regarding PP, no he is NOT AZ for sure, he is from the German Ariva board and was active there many years until January 2021 when he decided to not post there any more.

OT...re PLR


Seems the IRS uses the same format akin to the LT's former MOR reports that listed a history based upon the initial events.

I don't believe they were referring to the Jan 2020 PLR request but rather one that was made back in 2018 or so.


BTW...I could be wrong but I think PP is actually that jackhole AZ posting under an alias.

Can't wait to be rid of those morons or be hugely surprised by an Esc payout no matter how much...will take either one.

Nobody following EDAP?

IMO this company will be bought up by a big fish

Something is happening.

Remember the rumours years ago about GE Medical

News: $EDAP EDAP Announces Recent Focal One Sales Successes

Company completes four Focal One sales, including three bundled sales that combine Focal One® with Exact Imaging’s ExactVu micro ultrasound imaging solution Company recorded an additional three stand-alone ExactVu purchase orders at major centers LYON, France, July 15, 2020...

Find out more EDAP - EDAP Announces Recent Focal One Sales Successes

EDAP let's go

Very bullish on EDAP

I think the dollar jump in the last week was due to shorts covering and maybe some new Longs, for Q4 and Q1 results, bc they continue to grow and show profitability the last couple Qs. Also, expected reimbursement in the next year(?) Will continue to play to EDAP’s upside. Each FocalOne sale just builds a bigger recurring revenue stream and more value for the stock.

Yeah I follow this. I don’t expect to see much traction in the business until the cpt code on HIFU is official next year.

We aren’t seeing announcements on HIFU revenue so I assume the urology business grows modestly and HIFU may be erratic without a general upward direction.

I could be wrong of course. The January letter sounded bullish but was short on substance.

Anyone here

* * $EDAP Video Chart 07-25-2019 * *

Link to Video - click here to watch the technical chart video

News: $EDAP EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019

45% growth in total Q2 2019 revenue year-over-year   78% growth in HIFU sales year-to-date through June 30, 2019   Company to Report Second Quarter 2019 Financial Results on Wednesday, August 28, 2019 and to host conference call and webcast on Thursday August 29, at 8...

Read the whole news EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019

This sell off is providing another chance to buy and hold. Timing it is too difficult with such a thinly traded stock imo.

Been a long time coming for this one. Happy for everyone Still in it. I got back in at $1.50 in December but got out too soon at $3.

EDAP just an amazing run...this is why im the the number one technical trader right now in north america!!

EDAP a massive trending stock///see ya at 6.02!!

EDAP getting ready to blow up

EDAP what a monster move today!!!

EDAP my new monsta!!!

EDAP next nasy ready to blow up!!

Finally some life in EDAP!!!

Watch out for the shorters!!

Clay showed up today = inplay IMO

In my opinion, don't sell to fast.

I'm guessing GE Medical buys offers $17-$20 with in a year.

* * $EDAP Video Chart 04-02-2019 * *

Link to Video - click here to watch the technical chart video

I owned EDAP years ago but bailed out when the FDA screwed us.
The FDA has relented and now I'm wondering if that allows for insurance reimbursement, and is that happening?
gh

Still need an American ceo imo but good things happening!

We sold one!!! It's a start

!st positive blog I've seen in a while!

https://seekingalpha.com/article/4204728-edap-provides-rare-value-medtech?app=1

EDAP 3.11 start but wish 2.50.

Yes 2.11 was its base before news now a buck more.so seems usual without more news.

LMAO...the news of the decade finally arrives and this fckin POS is heading back to the $2's!

3.08 , now we can watch a slip to 2.50 during long silences.

It would but we have to many greedy day traders flinging this in sellin and then go to other acct to short it. Im waiitng again

I see masss accumulation arounf 3.35 so imho. I think your professor at BS college is telling you too come back bc you skip a course in college. They are telling you cant read. You own a hedge fund? Technically, you are not a owner or a person who would ever be hired at a hedge fund lmao.
3.40 to 3.45 today.
Fins coming out

Silence here all of a sudden?....yea, this stock is aggravating to say the least.

That news should have put EDAP at $7.

3.25 hit to the penny .how did you know I ran a hedge fund?

Glad you dont work for a hedge fund. Lose that job really fast.
Imo

Fins coming out soon, 4.00 to 4.25
Why would a huge deal come in invest so much.
Ideal this will go higher in time

Ok board is in Dunce mode. So I guess I have to do original research. lets see they have small cash burn and maybe a leading edge tool.So if 4.25 top up $2.05 then around 3.25 technical bounce but 2.50 just in case all that vol. explosion FRI. flees to OVERSELL DELIVERY SYSTEM.?

Keeep on shorting you little bastards

Their is a few shorts in this room not buyers. They will lose money today

Thank you sir. I was expecting 5.50 or 6. But 6.50 even better

Upgrade Buy to 6.50 price target by ValuEngine

https://www.marketbeat.com/stocks/NASDAQ/EDAP/?RegistrationCode=SocialMedia-direct&utm_source=GeneralSocialMedia&utm_medium=Social